Filing Details
- Accession Number:
- 0001181431-11-050416
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-26 09:31:16
- Reporting Period:
- 2011-09-22
- Filing Date:
- 2011-09-26
- Accepted Time:
- 2011-09-26 09:31:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242215 | C Joseph Papa | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | President And Ceo | Yes | Yes | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-09-22 | 2,500 | $92.35 | 118,912 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-09-22 | 7,000 | $93.53 | 111,912 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-09-22 | 500 | $93.92 | 111,412 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on August 23, 2011. This 10b5-1 sales plan will expire on the close of business August 22, 2012.
- The price in column 4 is a weighted average. The prices actually received ranged from $91.79 to $92.77. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $92.81 to $93.81. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $93.83 to $94.09. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
